Ichor Holdings
This is the archived full research. Read the story
Ichor builds the gas and chemical plumbing inside chip-making machines, mostly for Applied Materials and Lam Research.
The scores
Growth3/4 ↑
Revenue grew 11.6% in 2025 and 22.7% in Q2 2026, but it tracks equipment spending, rests on two customers and trails 2022.
Business quality2/4 ↑
One of two outsourced gas panel suppliers to Applied and Lam, but customers own the designs and parts follow SEMI standards.
Financial position3/4 ↑
About $136M of net cash after the share sale, but operating cash flow was minus $0.4M over four quarters as inventory grew.
Execution record2/4 ↑
A chief executive change, a 2025 restructuring with $19.8M of inventory write-downs, a missed Q2 midpoint, and an unpaid 2023 margin goal.
Per share capture2/4 →
Shares rose about 59% since 2020 through two share sales, while revenue per share fell from about $39 to $34.
Potential2/4 ↑
Equipment spending is forecast near $200B by 2028, but Ichor's share rests on purchase orders and a cycle others control.
Risk profile2/4 →
Applied and Lam bought 76% of 2025 sales on purchase orders, and either can move a platform to Ultra Clean or its own plants.
Valuation3/4 ↑
About 1.1 times sales and about 112% of a three-stage value near $30 on its best earlier margins: fair, inside the 20% margin of safety.
Evidence quality3/4 →
Results, the customer split, both suppliers' filings and SEMI's forecast are public; the margin path, capacity and order visibility rest on management's word.
The Verdict
We rate Ichor Neutral. It builds gas systems for chip-making machines, and its market is growing fast, but two customers buy three quarters of its sales, own the designs and keep a second supplier, so it keeps a thin slice of each sale: the business is mixed. Valued with margins back to its best earlier years, the shares are worth about $30, and at $33.65 the price is about 112% of that: it pays for the recovery, though not for more, when the cycle has turned hard before.
The long caseChipmakers are buying more deposition and etch tools for AI memory and logic, and every one needs gas delivery that Applied and Lam mostly buy from two suppliers.
How we weighed it
The price against our value
Cuts both ways
Price at 112% of our value
The price has fallen back inside the band a fifth above our value, with no company news, on a value that already assumes its best earlier margins; the bear case sits far below.
The business
Against it
Mixed
Gas systems for chip machines, but two customers own the designs and keep a second supplier.
Growth against what the price assumes
Against it
The value needs margins back to its best years, and the price now assumes faster growth than the equipment forecasts.
What could go wrong
Against it
Two customers dominate, the cycle turns hard, margins may stall and the share count keeps rising.
Against competitors
Cuts both ways
There is no filed cohort to compare, so the price is judged on its own.
How its group is behaving
Cuts both ways
Chip-equipment names move together on news about chipmakers' spending.
The latest news and report
Cuts both ways
The margin beat our test, but cash used keeps the earnings unproven.
What moved it from Unattractive
The shares gave back about half of the rise that moved the view, with no company news, and now sit inside the line a fifth above our value. Nothing about the business changed in either direction, so the price is the only input that moved.
The evidence under this - 7 claims
Ichor's own components raise the share of each panel it designs and owns (C08), and a tool cannot ship without its panel, which gives a supplier leverage in a shortage.
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
Analysts' 2027 earnings imply a non-GAAP margin near 10%; if the 20% gross margin target is reached and held, the value approaches the bull case's $55.07, above the price. The base margin is the best of Ichor's earlier years, not its average, which was lower.
- 2026-11-09editedRe-struck on the upgraded method: every view read at 9%, the return on new capital set by the moat, and capital per dollar of sales read from the filings.
- 2026-11-09editedRe-struck at the 8% required return the owner chose after the roll-out screen: the market priced the median name on the roster at about 7.7%, so 9% on top of a 20% margin read most of it Unattractive.
- 2026-11-09editedRe-struck on the decaying fade the owner chose on 9 November: after the stated path each year closes 30% of the gap to 4%, and an analysts' margin is cut by their gap to the filed operating profit.
- 2026-11-12editedbrought into line with the fair-value block re-struck on 10 November (base $30.07, bear $12.66, bull $55.07), which the claim had not followed, and the price re-struck at the 11 November close of $37.45, about 125% of the base case
- 2026-11-17editedprice re-read at the 16 November close of $33.65, about 112% of the unchanged base case, after route P1 fired; no input to the value moved
The company
A chip-making machine works by feeding exact amounts of gases and liquids into a chamber where a silicon wafer is etched or coated. Ichor builds the panels that do that metering: valves, pressure regulators and flow controllers joined by ultra-clean welded tubing.
It sells them to the companies that make the machines, which would otherwise build the panels themselves or buy from a rival. Ichor builds to the customer's own design, in plants in the United States, Mexico, Singapore and Malaysia.
The evidence under this - 3 claims
A standard footprint does not make a supplier's welding and clean-room line qualified on a customer's tool, which is where switching takes time.
How it makes money
Ichor is paid per panel and part shipped, on purchase orders with no minimum volumes, so its sales rise and fall with how many machines its customers build. Applied Materials bought 39% of 2025 sales and Lam Research 37%.
It keeps little of each sale: about 14 cents of every dollar after the cost of making it in Q2 2026, against about 50 cents at Lam.
The evidence under this - 4 claims
Where the money comes from, stream by stream
| Stream | Share of sales (FY 2025) | How it earns it |
|---|---|---|
| Applied Materials | 39% | Gas and chemical delivery systems, weldments and machined parts built to Applied's own designs. |
| Lam Research | 37% | Gas delivery systems and components built to Lam's designs for its process tools. |
| Other customers | 24% | Other equipment makers, including ASML, and aerospace and defense machining, under 10% of revenue. |
Who runs it
Phil Barros, an engineer who joined Ichor's engineering team in 2010 and ran its technology from 2015, became chief executive in November 2025. Greg Swyt has been finance chief since 2023.
Directors and officers own 1.7%. The chief executive sold 21,000 shares in February outside a pre-set plan. Pay rewards sales, margins and cash flow, and half the long-term award depends on 2027 margins and cash; the 2023 award paid nothing on its margin goal.
The evidence under this - 3 claims
Why it wins, and who could beat it
Why customers come back
Once Ichor's lines are approved to build a machine's panel, moving that work elsewhere means approving a new supplier, so customers tend to stay. Applied and Lam bought more from Ichor in 2025 than in 2023.
The hold is weak, though. The customers own the designs, order as they go and keep Ultra Clean approved as a second supplier, and the parts follow an industry standard. Ichor's sales to Lam are about 3% of what Lam spends making its machines, so Lam sets the terms.
The evidence under this - 6 claims
A standard footprint does not make a supplier's welding and clean-room line qualified on a customer's tool, which is where switching takes time.
Ichor's own components raise the share of each panel it designs and owns (C08), and a tool cannot ship without its panel, which gives a supplier leverage in a shortage.
The threat
Ultra Clean, twice Ichor's size, builds the same systems for the same two customers and names Ichor as its main rival. Fujikin, a private Japanese maker, and Compart Systems, owned by a Shanghai-listed group, also sell gas systems.
The customers can also build panels themselves; Ichor's own annual report says it already competes with their in-house groups.
The evidence under this - 4 claims
The rivals: UCTT, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| UCTT | Ultra Clean HoldingsPriced against it: Same product | Fluid delivery subsystems for chip equipment | On sale | Same product |
| Private | FujikinPriced against it: Private | Fluid delivery subsystems for chip equipment | On sale | Private |
| Compart Systems, owned by Shanghai Vital MicrotechPriced against it: Listed abroad | Fluid delivery subsystems for chip equipment | On sale | Listed abroad | |
| In-house | Applied Materials' and Lam Research's own manufacturingPriced against it: In-house | Fluid delivery subsystems for chip equipment | On sale | In-house |
How big it could get
How big this could get
Nobody outside the companies publishes how much of a machine's cost is its gas system, so the market cannot be sized exactly. What can be measured is the spending it rides: the industry body SEMI expects chipmakers to spend $143.9B on wafer-making machines in 2026 and about $200B by 2028.
Ichor's 2025 sales were about 0.8% of that spending. Ichor and Ultra Clean together sold about $2.7B of these products.
The evidence under this - 4 claims
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
SEMI's total includes lithography and inspection tools, where Ichor sells little, so its share of the tools it actually serves is higher.
The results
The numbers
Sales grew 15% over the twelve months to Sep 2026, about the same pace as the 12% in the year to Dec 2025.
Operating margin is 1.7%, up from −1.3% in the year to Dec 2023.
Running costs take 12¢ of each sales dollar, up from 9¢ in the year to Dec 2021.
Shareholders' money earned 0.4% a year, down from 16% in the year to Dec 2021.
It used $67.2M of cash over the last twelve months, so the $214M it holds lasts about 3.2 years at that pace.
It holds $214M of cash against $119M of debt, $94.4M more cash than it owes.
The share count rose 32% in 4.7 years, and pay in shares costs 1.4% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $1.10B | $1.28B | $811M | $849M | $948M | $1.10B |
| Sales growth | +20% | +17% | −37% | +4.7% | +12% | +15% |
| Profit | ||||||
| Gross margin | 16% | 17% | 13% | 12% | 9.3% | 13% |
| Operating margin | 7.4% | 6.7% | −1.3% | −0.9% | −4.1% | 1.7% |
| Net margin | 6.5% | 5.7% | −5.3% | −2.5% | −5.6% | 0.3% |
| What growth costs, per sales dollar | ||||||
| Research and development | 1.4% | 1.5% | 2.5% | 2.7% | 2.4% | 2.2% |
| Selling, general and admin | 6.0% | 6.9% | 9.8% | 9.3% | 10% | 8.6% |
| Pay in shares | 1.0% | 1.1% | 2.1% | 1.8% | 1.8% | 1.4% |
| Capital spending | 1.9% | 2.3% | 1.9% | 2.1% | 3.8% | 2.6% |
| Cash | ||||||
| Cash from operations | $15.3M | $31.5M | $57.6M | $27.9M | $29.9M | −$38.4M |
| Free cash flow | −$5.57M | $2.02M | $42.1M | $10.2M | −$6.28M | −$67.2M |
| Balance sheet | ||||||
| Cash and short-term investments | $75.5M | $86.5M | $80.0M | $109M | $98.3M | $214M |
| Debt | $293M | $301M | $249M | $129M | $124M | $119M |
| Net cash | −$217M | −$214M | −$169M | −$19.9M | −$25.2M | $94.4M |
| Returns and shares | ||||||
| Return on capital | 11% | 9.9% | - | - | - | - |
| Shares (diluted) | 29.0M | 29.0M | 29.2M | 32.8M | 34.2M | 38.2M |
What growth costs
Right now growth is making the business more profitable: as quarterly sales rose 23% since September 2025, the share kept after production costs more than doubled, partly because one-off closure costs ended. The same fixed costs work in reverse in a downturn: in 2023 a 37% fall in sales cut that share by a quarter.
The evidence under this - 4 claims
Part of the rise is the end of 2025's restructuring charges and write-downs (C09) rather than leverage, and non-GAAP gross margin rose only from 12.1% to 14.1%.
The September 2025 quarter carried most of the restructuring charges and inventory write-downs (C09), so part of the margin rise is charges ending rather than the business improving.
- 2026-11-03editedRolled forward one quarter to include September: the 10-Q filed 3 November gives nine-month sales of $879.6M, which with the December 2025 quarter makes $1,103.2M, the base the price is now measured against.
The last report (2 Nov)
Quarter ended September 2026, filed figures.
In Q3 2026 sales rose 37% from a year earlier to $328.7M, inside the $315M to $345M forecast. The share of each sales dollar kept after production costs rose to 16.0% from 14.1%, above the 14.5% to 15.5% forecast, and earnings were 63 cents a share before stock pay. Next quarter is forecast at $345M to $365M.
Cash went the other way: Ichor used $28.8M in operations as it stocked $330.2M of parts. On the call management said every 2027 quarter should grow, profit should grow over twice as fast as sales, and customers now cover parts it buys if they do not move.
What it did to the thesisThe margin beat our test and the call outlined 2027 growth, while cash used keeps the earnings unproven.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $0.63 against $0.45 expected.
The evidence under this - 4 claims
Q2 revenue already came in below the guide's midpoint on a part shortage (C04, C27), and the guide rests on customers' forecasts rather than contracts (C12).
- 2026-11-02editedQ3 2026 release read: the guide became a filed outcome; revenue inside the range, gross margin above it, and a December-quarter guide added.
Gross margin has never been above 16.6% in a year (C06), and the 2023 performance shares paid nothing on their gross margin goal (C25).
- 2026-11-02editedQ3 2026 release: gross margin rose 1.9 points in the quarter, ahead of the roughly one point planned; the 20% path and component share are still management's.
- 2026-11-03editedQ3 2026 call: own components passed 30% of gas system content a quarter early, 35% is targeted for the end of Q4 and 40% near term, incremental margin is guided at least 25% for 2027 and the December margin outlook is 16.5%; the 20% path remains management's.
- 2026-11-02editedQ3 2026 release balance sheet re-struck: cash, debt, inventory and equity at 25 September; no share sale in the quarter.
- 2026-11-03editedQ3 2026 call and 10-Q: customers backstop inventory Ichor buys, which limits the stranded-parts risk behind the cash use; nine-month operating cash use of $47.6M and the share count of 37.58M added.
- Orders are purchase orders without minimum volumes (C12), and the 2027 outline is the company's own, given before its customers' plans are final.
- The December range was cut by about $10M from an earlier view for a customer launch delay and part shortages (C27).
What management did with the money
Management sold $200M of new shares in mid-2026, at nearly three times the price of a year earlier, and closed higher-cost plants in 2025. The sale was well timed, but each new share shrinks existing holders' slice: the share count is up about 59% since 2020.
Insiders in 2026Q3: 0 purchases and 23 sales, from their Form 4 filings.
The evidence under this - 3 claims
- 2026-11-02editedQ3 2026 release balance sheet re-struck: cash, debt, inventory and equity at 25 September; no share sale in the quarter.
- 2026-11-03editedQ3 2026 call and 10-Q: customers backstop inventory Ichor buys, which limits the stranded-parts risk behind the cash use; nine-month operating cash use of $47.6M and the share count of 37.58M added.
The price, and where we disagree
In short. Fair. The price is about 112% of what we think the business is worth, at an 8% yearly return, inside a 20% cushion.
The shares peaked on 30 June after a year-long run and have fallen 67% since, 15% of it since 21 October. Almost all of the year's rise came from buyers paying more for each dollar of sales, and that has largely reversed.
The September results landed after our last look: the margin came a quarter early, and management outlined growth in every 2027 quarter. The next test is the December quarter, due in early February.
The evidence under this - 5 claims
- 2026-10-22editedre-struck at the 2026-10-21 close of $43.34 (from $63.33) on the daily review's maintenance route -- drift -31.6%, past the 12% trigger. Trailing sales, share count and 2027 consensus EPS held as struck on 5 October; no new print or filing since.
- 2026-11-03editedRe-struck at the 2 November close of $36.84 (from $43.34), the first close after the September quarter was reported, with the 10-Q share count of 37.58M and September's cash and debt; the 5 October decomposition is kept as history.
Q2 revenue already came in below the guide's midpoint on a part shortage (C04, C27), and the guide rests on customers' forecasts rather than contracts (C12).
- 2026-11-02editedQ3 2026 release read: the guide became a filed outcome; revenue inside the range, gross margin above it, and a December-quarter guide added.
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
- Orders are purchase orders without minimum volumes (C12), and the 2027 outline is the company's own, given before its customers' plans are final.
- The December range was cut by about $10M from an earlier view for a customer launch delay and part shortages (C27).
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- No moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 31%, 0%, 0% | 31%, 25%, 12% | 31%, 32%, 15% |
| Normal operating margin | 4% | 7% | 9% |
| Return on new capital after year ten | 8% | 8% | 11% |
| Value a share | $12.66 | $30.07 | $55.07 |
- Price
- $33.65
- Priced on
- 16 Nov
- Price as a share of the base value
- 112%
- Starting growth the price pays for
- 33.4%
- Yearly return the price offers on the base case
- 7.6%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $22.14
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last full year | Filed report | Annual report (10-K) for the period to 26 Dec 2025, filed 20 Feb 2026; the full year. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 3 Nov 2026; the four quarters to that date. |
| Tax rate | Our judgement | Our reading of the evidence. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 26 Dec 2025, filed 20 Feb 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 3 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 3 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 3 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Our judgement | Our reading of the evidence, set against the analysts' forecasts and the company's guidance; the base case below says where it follows them and where it departs. FMP's consensus of 2 to 6 analysts read 37.6%, 15.8%, 15%. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 26 Dec 2028, the average of 5 analysts' estimates, 10.8%, less stock pay of 1.4% of sales and less the 3% the analysts add back on their adjusted basis: 6.3%, which the base case takes as 7%. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our judgement | Our reading of the evidence; each case below names it. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseThe equipment cycle turns in 2027 as it did in 2023, when sales fell 36.6% (C06): revenue is flat for two years, the margin settles at 4% because Applied and Lam set it (C28), and new capital earns only its 9% cost.
Base case2026 grows about 31% to analysts' $1,239.6M (C20), with December guided to $345M to $365M (C29); 2027 grows 25%, about SEMI's 21.8% equipment forecast plus Ichor's own content gains (C16, C08), and 2028 12%; the GAAP operating margin, after stock pay and amortisation, rises from 1.7% to 7%, about 2021 and 2022's 7.4% and 6.7% (C06).
Bull caseSales reach analysts' 2027 figure of $1,629.6M (C20) and grow 15% more, and the 20% gross margin target (C08) lifts the GAAP operating margin to 9%, above any earlier year.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $26.65 | $34.01 |
| The normal margin, 15% lower or higher | $24.77 | $35.37 |
| Capital per dollar of growth, a quarter more or less | $27.20 | $31.80 |
| Return on new capital after year ten, at the rate or one step up | $30.07 | $37.39 |
| The rate, a point higher or lower | $23.38 | $41.30 |
| Long-run growth a point lower | $29.46 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 5.6% | $18.79 | $20.75 | $23.01 | $25.61 | $28.57 |
| 6.3% | $21.24 | $23.70 | $26.54 | $29.81 | $33.54 |
| 7% | $23.68 | $26.65 | $30.07 | $34.01 | $38.50 |
| 7.7% | $26.13 | $29.60 | $33.61 | $38.21 | $43.46 |
| 8.4% | $28.57 | $32.55 | $37.14 | $42.41 | $48.43 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
A buyer pays for most of the recovery working.
1. Analysts expect $3.27 a share in 2027, about twice 2026's, before stock pay and amortisation. 2. That needs sales about 48% above the last four quarters' and a margin near the 2022 peak.
Valued on profit after those costs, with margins back to its best earlier years, the shares are worth about $30.
Against its own history. Buyers pay about an eighth more than Ichor's usual price for each dollar of its sales, while its margin nears its last peak.
The evidence under this - 6 claims
- Management targets 20% gross margin with more of its own components inside each panel (C08), which would make 2027 consensus conservative and the multiple lower.
- The 2027 consensus was struck before the September results and will move; if it rises, the multiple is lower still, and if the cycle turns before margins arrive the same earnings do not come (C03, C16).
- 2026-10-22editedre-struck at the 2026-10-21 close of $43.34 (from $63.33) on the daily review's maintenance route -- drift -31.6%, past the 12% trigger. Trailing sales, share count and 2027 consensus EPS held as struck on 5 October; no new print or filing since.
- 2026-11-03editedRe-struck at the 2 November close of $36.84 on trailing sales of $1,103.2M including September; 2027 consensus EPS still the 5 October figure. The price no longer pays for the full margin recovery because the margin is already near 16% and guided higher.
- 2026-10-22editedre-struck at the 2026-10-21 close of $43.34 (from $63.33) on the daily review's maintenance route -- drift -31.6%, past the 12% trigger. Trailing sales, share count and 2027 consensus EPS held as struck on 5 October; no new print or filing since.
- 2026-11-03editedRe-struck at the 2 November close of $36.84 (from $43.34), the first close after the September quarter was reported, with the 10-Q share count of 37.58M and September's cash and debt; the 5 October decomposition is kept as history.
The September 2025 quarter carried most of the restructuring charges and inventory write-downs (C09), so part of the margin rise is charges ending rather than the business improving.
- 2026-11-03editedRolled forward one quarter to include September: the 10-Q filed 3 November gives nine-month sales of $879.6M, which with the December 2025 quarter makes $1,103.2M, the base the price is now measured against.
Analysts' 2027 earnings imply a non-GAAP margin near 10%; if the 20% gross margin target is reached and held, the value approaches the bull case's $55.07, above the price. The base margin is the best of Ichor's earlier years, not its average, which was lower.
- 2026-11-09editedRe-struck on the upgraded method: every view read at 9%, the return on new capital set by the moat, and capital per dollar of sales read from the filings.
- 2026-11-09editedRe-struck at the 8% required return the owner chose after the roll-out screen: the market priced the median name on the roster at about 7.7%, so 9% on top of a 20% margin read most of it Unattractive.
- 2026-11-09editedRe-struck on the decaying fade the owner chose on 9 November: after the stated path each year closes 30% of the gap to 4%, and an analysts' margin is cut by their gap to the filed operating profit.
- 2026-11-12editedbrought into line with the fair-value block re-struck on 10 November (base $30.07, bear $12.66, bull $55.07), which the claim had not followed, and the price re-struck at the 11 November close of $37.45, about 125% of the base case
- 2026-11-17editedprice re-read at the 16 November close of $33.65, about 112% of the unchanged base case, after route P1 fired; no input to the value moved
Priced against its rivals
Only Ultra Clean Holdings sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Private or foreign rivals that cannot be priced: Fujikin Incorporated, Compart Systems.
Where we disagree with the market
An AI-driven equipment boom with margins recovering, though the shares have fallen 67% since June.
The boom is real and the price pays for the recovery, but two customers set Ichor's margins and may stop short of 20%.
In the last boom Ichor's margin peaked at 16.6% on $1.28B of sales, and a 2023 pay goal on margins paid nothing. Management now counts on making more of the parts inside each panel itself, and passed 30% of content in September.
Against us: management says supply constraints are starting to loosen, customers order about six months ahead, and the industry body expects spending to rise 21.8% again in 2027.
What analysts say, and the evidence
The evidence under this - 7 claims
Gross margin has never been above 16.6% in a year (C06), and the 2023 performance shares paid nothing on their gross margin goal (C25).
- 2026-11-02editedQ3 2026 release: gross margin rose 1.9 points in the quarter, ahead of the roughly one point planned; the 20% path and component share are still management's.
- 2026-11-03editedQ3 2026 call: own components passed 30% of gas system content a quarter early, 35% is targeted for the end of Q4 and 40% near term, incremental margin is guided at least 25% for 2027 and the December margin outlook is 16.5%; the 20% path remains management's.
Ichor's own components raise the share of each panel it designs and owns (C08), and a tool cannot ship without its panel, which gives a supplier leverage in a shortage.
Orders six months out are still purchase orders without minimum volumes (C12), and a dependence on outside flow controllers is what the internal content plan (C08) is meant to cure.
- 2026-11-03editedQ3 2026 call: supply constraints are described as starting to loosen, the December revenue range was lowered by about $10M for a space launch delay and part shortages, and flow control is a 2027 revenue event.
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
What could go wrong, and how we would know
The risks
- Two customers Applied Materials and Lam Research bought 76% of 2025 sales on purchase orders and can move work to Ultra Clean or their own plants.
- The cycle turns In 2023 sales fell 37% when chipmakers paused, and the shares fell 62% before it, while sales were still growing.
- Margins stall The price assumes margins near the last peak; if they stall near 15%, 2027 profit falls about a fifth short.
- More shares The share count is up about 59% since 2020, and new shares have been sold in each recovery.
- Parts shortages A flow controller supplier's shortage already cost sales in Q2 2026, and the chief executive named it a worry.
- Tax holiday ends Ichor's Singapore tax break expires in 2026, so more of each dollar of profit goes in tax.
The evidence under this - 7 claims
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
Orders six months out are still purchase orders without minimum volumes (C12), and a dependence on outside flow controllers is what the internal content plan (C08) is meant to cure.
- 2026-11-03editedQ3 2026 call: supply constraints are described as starting to loosen, the December revenue range was lowered by about $10M for a space launch delay and part shortages, and flow control is a 2027 revenue event.
What we still do not know
- How much of a chip-making machine's cost is its gas system; no one outside the companies publishes it.
- How Applied and Lam split their orders between Ichor, Ultra Clean and their own plants.
- Whether Fujikin or Compart has won business from Ichor at Applied or Lam since 2023.
The evidence under this - 3 claims
SEMI's forecasts are revised with the cycle: this one was a large upward revision from its 2025 year-end forecast, and equipment spending fell sharply in 2023, when Ichor's revenue fell 36.6% (C06).
What would change our view
- Neutral→UnattractiveThe price runs 20% above fair value
It needs:
- ○The share price rises to about $36, 20% above what we think the business is worth.about ≈$36.14 today, -43% above the last close
- Neutral→AttractiveThe price falls 20% below fair value
It needs:
- ○The share price falls to about $24, 20% below what we think the business is worth.about ≈$23.37 today, 63% below the last close
We would also be wrong if
- Gross margin passes 20% and holds through a downturn year.
- Ichor wins a third large equipment customer.
What is coming
- 2 November 2026 Q3 2026 results: Whether revenue reaches the $330M midpoint, gross margin lands inside 14.5% to 15.5%, and the Q4 guide keeps rising.
Every dated event ahead
- 2 November 2026 Q3 2026 results: Whether revenue reaches the $330M midpoint, gross margin lands inside 14.5% to 15.5%, and the Q4 guide keeps rising.
- 31 December 2026 SEMI year-end equipment forecast: Whether the industry body holds its 21.8% growth forecast for 2027 equipment spending.
- 15 February 2027 Q4 2026 results: Whether 2026 revenue grew at least 30%, gross margin reached about 16%, and the lithography customer returned.
Since we wrote this
- 17 NovPrice moveBack to Neutral: the price fell inside 120% of our valueA fall of about a tenth in three sessions, with no company news, took the shares back to about 112% of our $30 value: a price that pays for the recovery but not for more.
- 12 NovPrice moveMoved to Unattractive: the price passed 120% of our $30 valueA rise of about a fifth in three sessions, with no company news, took the shares to about 125% of our value; a supplier whose customers set its margin has nothing that earns the premium.
- 9 NovThesis reviewNeutral: about fair against a value of about $34Re-valued in three stages at an 8% return, the method now drawn on every Attractive thesis: the price sits within 20% of its base-case value.
- 3 NovEarningsShares fall under our price line as margin runs ahead; now AttractiveThe 2 November close of $36.84 is 1.17 times trailing sales against the 1.3 line, and the call showed margin a quarter early and 2027 growing every quarter.
- 2 NovEarningsSales $328.7M, margin 16.0% above plan; cash used in operations; view holdsMargin rose faster than planned and December is guided up, but inventory absorbed cash and the price line for Attractive was not crossed.
- 22 OctPrice movePrice re-struck, -31.6%; view heldNo print or news since 5 October. The shares cost about 1.5 times sales rather than 2.2, but the 2027 profit behind 13 times still needs peak margins.
- 6 OctThesis writtenNeutral, medium convictionWritten with the shares up threefold in a year, almost all on a higher multiple, a month before the Q3 print.
Also checked 3 times with nothing new to act on.
Sources 21
Sources - 21
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-20products, plants, employees, customer concentration, design rights and purchase orders, the named competitor, restructuring, tax holiday and the FY2025 statementsbacksC01C02C03C09C12C13C14
- S02primarycompany release2026-02-09Q4 and Q3 2025 results, non-GAAP margins and EPS, and the full-year reconciliationbacksC02C05C09
- S03primarycompany release2026-08-03Q2 2026 results, non-GAAP reconciliation and the Q3 guidebacksC04C05C20C22
- S04primarycompany filing2026-08-04the balance sheet, cash flow, the share sale and the share countbacksC04C10C11C19
- S05primarycompany release2026-05-04Q1 2026 revenue, margins and EPSbacksC05
- S06primarytranscript2026-08-03Ichor Q2 2026 earnings call transcript (FMP), held 3 August 2026the second-half and full-year outlook, the margin plan and the 20% path, internal content, capacity, the flow controller shortage, order visibility and the lithography customer
We have the capacity today to support $500 million in quarterly revenue.
backsC08C27 - S07primarycompany filing2026-04-01major holders, director and officer ownership, the chief executive's pay, the bonus metrics and the performance share goals and resultsbacksC23C24C25
- S08primarycompany filing2026-05-18the size and terms of the share sale programmebacksC10
- S09primarycompany filing2026-02-23its principal gas delivery competitors, its revenue by segment and its customer concentrationbacksC13
- S10primaryindustry data2026-10-06the industry standard for flow controller footprints in surface-mount gas panels
This Standard establishes the properties and physical dimensions of mass flow controllers and mass flow meters for 1.125 inch type surface mount gas distribution systems.
backsC14 - S11primarycompany filing2026-08-07Lam's revenue, gross margin, manufacturing model and outsourcingbacksC15
- S12primaryindustry data2026-07-15wafer fab equipment sales for 2025 and the forecast to 2028, with memory and logic splits
WFE segment sales are projected to expand 21.8% in 2027 and 14.1% in 2028 to reach the $200 billion mark
backsC16 - S13primaryother2020-12-22the buyer, the price and what Compart makes
DC Advisory (DC) acted as financial advisor to Shanghai Wanye on its acquisition of Compart Systems for USD 398 Mn.
backsC17 - S14secondaryvendor data2026-10-05Research pack (FMP market data, FINRA, SEC filed figures), frozen as research-pack.jsonprice, range and the price move split, the multiples against their own six-year medians, analyst estimates, ratings and the rating series, short interest and insider tradesbacksC19C20C22C23
- S15primarycompany filing2025-08-04Jeff Andreson's planned departure and the search for a successorbacksC24
- S16primarycompany filing2025-11-03Barros's appointment and careerbacksC24
- S17primarycompany filing2026-10-06six years of filed revenue, gross profit, operating income, net income, cash flow, capital spending and diluted share countsbacksC05C06C11C22C30
- S30primarycompany filing2026-11-02third-quarter revenue, gross and operating margin, EPS, balance sheet and cash flow, and the fourth-quarter outlookbacksC07C08C10C30
- S31primarytranscript2026-11-02Ichor Holdings Q3 2026 earnings call transcript (FMP), held 2026-11-02The December guide and its cut for a commercial space launch delay, 2027 parameters (every quarter growing, earnings growth over twice revenue growth, expenses up about 15%, incremental gross margin at least 25%), own components at about 30% exiting Q3 and 35% exiting Q4, customers backstopping inventory, supply constraints loosening.
we expect every quarter in 2027 will be a growth quarter for Ichor. We expect to deliver continued gross margin expansion as we move through the year, and we expect Ichor's earnings growth in 2027 will outpace revenue growth by over 2x.
backsC08C10C27C29 - S32primarycompany filing2026-11-03Net sales of $328.7M for the quarter and $879.6M for nine months, net cash used in operating activities of $47.6M and capital expenditures of $25.5M for nine months, and 37,576,306 shares outstanding at 27 October 2026.backsC05C10C19C30
- S33secondaryvendor data2026-11-02FMP end-of-day price history, ICHR, closing price of 2 November 2026The 2 November 2026 close of $36.84, used to re-strike the price claims.backsC19